跳至主要内容
临床试验/NCT04158167
NCT04158167已完成不适用

Neurobiological Effects of Oxytocin on Metacognitive Deficits in Schizophrenia: A Pharmacological - Imaging Genetics Study

National Institute of Mental Health and Neuro Sciences, India1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2013年9月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
90
试验地点
1
主要终点
fMRI changes with oxytocin

研究概览

简要总结

To investigate whether 24IU oxytocin can result in changes in functional brain connectivity in patients with schizophrenia and healthy individuals using functional magnetic resonance imaging (fMRI). The study will also examine the effect of oxytocin receptor gene polymorphism on the functional connectivity

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • 未提供

排除标准

  • Schizophrenia subjects:
  • Inclusion criteria 1) Males between 18 and 50 years 2) Diagnosis of DSM-IV schizophrenia, schizoaffective or schizophreniform disorder 3) capacity to provide informed consent, as evaluated by the MacArthur Competence Assessment Tool for Clinical Research Exclusion criteria
  • General impairment in intellectual functioning
  • History of alcohol or substance dependence in the last 12 months (with the exception of nicotine)
  • Contraindication to oxytocin like hypersensitivity, vascular disease, chronic nephritis, epilepsy, asthma
  • Past history of head injury resulting in loss of consciousness or neurosurgery
  • Concomitant severe medical conditions
  • Metal implants or paramagnetic objects within the body or claustrophobia which may interfere with the MRI.
  • Healthy volunteers:
  • Inclusion criteria
  • Males between 18 and 50 years
  • Capacity to provide informed consent Exclusion criteria
  • Life-time diagnosis of psychiatric illnesses including substance abuse 2) General impairment in intellectual functioning 3) Past history of head injury resulting in loss of consciousness or neurosurgery 4) Concomitant severe medical or neurological conditions 5) Metal implants or paramagnetic objects or claustrophobia 6) Family history of schizophrenia, schizoaffective or schizophreniform disorder in family member (sibling, parent or offspring) 7) Contraindication to oxytocin like hypersensitivity, vascular disease, chronic nephritis, epilepsy, asthma.

研究组 & 干预措施

oxytocin

Other

All subjects will receive both oxytocin and placebo in a counterbalanced design

干预措施: oxytocin (Drug)

结局指标

主要结局

fMRI changes with oxytocin

时间窗: Upto 90 minutes after administration

changes in functional brain connectivity

次要结局

未报告次要终点

研究者

发起方
National Institute of Mental Health and Neuro Sciences, India
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr Naren P Rao

Additional Professor

National Institute of Mental Health and Neuro Sciences, India

研究点 (1)

Loading locations...

相似试验